Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Nucl Med Biol. 2013 Feb 27;40(4):451–457. doi: 10.1016/j.nucmedbio.2013.01.007

Figure 4.

Figure 4

Tumor uptake of 89Zr-panitumumab in various subcutaneous athymic nude female xenograft models; 10.18±1.24 MBq of 89Zr-panitumumab were administered intravenously via tail-vein, and a 5 min CT scan followed by a 30 min static PET scan were performed at 96 h post-injection.